{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:16:12Z","timestamp":1770455772486,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.025","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T20:33:44Z","timestamp":1536352424000},"page":"3563-3569","source":"Crossref","is-referenced-by-count":13,"title":["Screening for Fabry Disease in Japanese Patients with Young-Onset Stroke by Measuring \u03b1-Galactosidase A and Globotriaosylsphingosine"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-6940","authenticated-orcid":false,"given":"Naoto","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7486-9700","authenticated-orcid":false,"given":"Naohisa","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Yagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemori","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Torii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Sueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuko","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Nezu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0067-3235","authenticated-orcid":false,"given":"Hiroki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1012443001449","article-title":"An historical overview of Fabry disease","volume":"24","author":"Fabry","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry's disease","volume":"40","author":"Mitsias","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0003","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0004","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0006","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.clineuro.2007.03.008","article-title":"Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke","volume":"109","author":"Brouns","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0007","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/STROKEAHA.109.558320","article-title":"Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke","volume":"41","author":"Wozniak","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0008","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/STROKEAHA.109.570499","article-title":"Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study\u2014screening genetic conditions in Portuguese young stroke patients","volume":"41","author":"Baptista","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0009","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/STROKEAHA.110.579409","article-title":"Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease","volume":"41","author":"Brouns","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0010","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1468-1331.2012.03737.x","article-title":"Zurich Fabry study\u2013prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA","volume":"19","author":"Sarikaya","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0011","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1468-1331.2012.03739.x","article-title":"Fabry disease in unselected patients with TIA or stroke: population-based study","volume":"19","author":"Marquardt","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0012","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/STROKEAHA.112.663708","article-title":"Acute cerebrovascular disease in the young: the stroke in young Fabry patients study","volume":"44","author":"Rolfs","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0013","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.10.005","article-title":"Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke","volume":"22","author":"Dubuc","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0014","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.07.012","article-title":"De novo diagnosis of Fabry disease among Italian adults with acute ischemic stroke or transient ischemic attack","volume":"24","author":"Romani","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0015","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.02.004","article-title":"The frequency of Fabry Disease among young cryptogenic stroke patients in the city of Sakarya","volume":"26","author":"G\u00fcndo\u011fdu","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0016","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/STROKEAHA.116.016083","article-title":"Prevalence of Fabry Disease and outcomes in young Canadian patients with cryptogenic ischemic cerebrovascular events","volume":"48","author":"Lanthier","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41436-018-0258-3","article-title":"Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis","author":"Maruyama","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0019","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2215\/CJN.08780812","article-title":"Screening of male dialysis patients for Fabry disease by plasma globotriaosylsphingosine","volume":"8","author":"Maruyama","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0021","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jns.2007.01.053","article-title":"The cerebral vasculopathy of Fabry disease","volume":"257","author":"Moore","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00868342","article-title":"Stroke in Fabry's disease","volume":"241","author":"Grewal","year":"1994","journal-title":"J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0023","first-page":"741","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"1802","author":"Aerts","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00207037","article-title":"Point mutations in the upstream region of the alpha-galactosidase A gene exon 6 in an atypical variant of Fabry disease","volume":"89","author":"Ishii","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ymgme.2012.01.010","article-title":"Fabry disease: biochemical, pathological and structural studies of the \u03b1-galactosidase A with E66Q amino acid substitution","volume":"105","author":"Togawa","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/ene.12214","article-title":"p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males","volume":"21","author":"Nakamura","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0027","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/jhg.2017.31","article-title":"Prevalence of Fabry disease and GLA c.196G>C variant in Japanese stroke patients","volume":"62","author":"Nagamatsu","year":"2017","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0028","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0029","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1159\/000250968","article-title":"Prevalence and cardiovascular features of Japanese hemodialysis patients with Fabry disease","volume":"30","author":"Fujii","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/jhg.2010.58","article-title":"Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns","volume":"55","author":"Lee","year":"2010","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0031","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/jhg.2012.68","article-title":"High-throughput screening identified disease-causing mutants and functional variants of \u03b1-galactosidase A gene in Japanese male hemodialysis patients","volume":"57","author":"Doi","year":"2012","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0032","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ijcard.2012.10.076","article-title":"Screening for Fabry disease in patients with left ventricular hypertrophy","volume":"167","author":"Mawatari","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0033","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10157-014-0969-y","article-title":"Role of the p.E66Q variant of GLA in the progression of chronic kidney disease","volume":"19","author":"Watanabe","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.025_bib0034","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10157-015-1146-7","article-title":"Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST)","volume":"20","author":"Saito","year":"2016","journal-title":"Clin Exp Nephrol"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718304671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718304671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T13:35:37Z","timestamp":1549287337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718304671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1052305718304671"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.08.025","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}